Australia's most trusted
source of pharma news
Wednesday, 20 August 2025
Posted 18 August 2025 AM
BeiGene has officially adopted its new name BeOne Medicines across Australia and New Zealand as part of a phased rollout around the world.
The new name and accompanying new logo, pitched late last year before being approved by shareholders on 28 April better reflects the company’s vision to unite the worldwide community in the fight against cancer.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.